Caenorhabditis Genetics Center (CGC)
COVID-19 Impacts on the CGC (1 September 2020 update)
As of the date and time listed above, the CGC has resumed nearly full operations. We are now accepting new orders with our pre-COVID limit of 50 strains per order. Please note that processing times might still be longer than usual given our new mode of operation with shift work, social distancing, and additional safety measures in the lab. Also please note that delays due to the USPS and other possible interruptions of international mail services are beyond our control. The situation remains dynamic, and we will continue to adjust our activities to meet University and government-issued guidelines.
ALL USERS PLEASE NOTE:
1. We do not yet have the capacity to provide free re-sends. Strains that do not reach their destination or die in transit will need to be reordered. We will carefully prepare each stock to give it the best chance of arriving safely, but we will not guarantee viability of the strains considering the unprecedented risks of delays in shipping, customs clearance, and final delivery to the end user. It is the responsibility of the end user to retrieve packages from Customs in a timely manner.
2. The time window to report problems associated with shipments impacted by COVID-19 prior to the shutdown of March 27, 2020 has now passed.
LABS OUTSIDE THE USA: We welcome international orders. International shipping continues to be slow, and many countries still have restrictions in place on international shipments. Before placing any orders, please confirm that your country is currently receiving shipments from the US, your local postal delivery service is not experiencing long delays, and that your institution is open to receive the package!
USA USERS: Please be sure that you will be able to receive shipments at your institution before placing any new orders.
Updates related to CGC activities will be posted on our website.
Hope you are all still staying safe!
-CGC Staff
Follow us on Twitter: @cgc_worms
Strains obtained from the CGC may not be redistributed outside of the recipient's organization without our written consent. See our Conditions of Use.
About the CGC
The Caenorhabditis Genetics Center (CGC) is supported by the National Institutes of Health - Office of Research Infrastructure Programs (P40 OD010440). The CGC has been in operation since 1978, first at the University of Missouri, Columbia and since 1992 at the University of Minnesota, Twin Cities.
Ann Rougvie is the director; Aric Daul is the curator. The CGC collects, maintains, and distributes stocks of C. elegans.
Canadian Users: Due to the cold weather, we highly recommend you provide a Fedex account number during the months of December through February. It may be entered in the Comments section while placing your order.
Please note: The National Institutes of Health mandates that CGC recovers a portion of our costs by charging fees for services.
All users (e.g. a Laboratory or Company) will be charged an annual account fee of $30. In addition, all users shall pay a flat fee per strain. In the case of academic/non-profit organizations, a $10.00 fee per strain shall be paid by the recipient. For commercial organizations, a $150.00 fee per strain shall be paid by the recipient. Additionally, to partially offset the higher costs of sending strains internationally, a small processing charge will be added to each international order:
1-7 strains: $3
8-15 Strains: $5
>15 strains: $8
Although all users of the collection are expected to pay their fees, fees for use in academic research may be waived under certain circumstances. If stocks will be used for academic research and you do not have grant or institutional funds (including start-up) with which to pay your fees, a waiver may be granted. To be considered for a waiver, send your strain request together with a brief explanation of your situation and justification of the waiver request to the CGC Director (Rougvie@umn.edu) prior to submitting your order through our website.
ATTENTION HIGH SCHOOL STUDENTS: Your instructor must be included on ALL correspondence when requesting strains.
CONTACT US
Funded by:
National Institutes of Health - Office of Research Infrastructure Programs (P40 OD010440)